Comparative effectiveness of umeclidinium/vilanterol versus inhaled corticosteroid/long-acting β2-agonist in patients with chronic obstructive pulmonary disease in a primary care setting in England

Comparing adherence to once-daily UMEC/VI, a long-acting muscarinic antagonist/long-acting β2-agonist and twice-daily inhaled corticosteroids in COPD

Saved in:

Bibliographic Details
Main Authors:	Czira, Alexandrosz (Author) , Requena, Gema (Author) , Banks, Victoria (Author) , Wood, Robert (Author) , Tritton, Theo (Author) , Castillo, Catherine M. (Author) , Yeap, Jie (Author) , Wild, Rosie (Author) , Compton, Chris (Author) , Rothnie, Kieran J. (Author) , Herth, Felix (Author) , Quint, Jennifer K. (Author) , Ismaila, Afisi S. (Author)
Format:	Article (Journal)
Language:	English
Published:	19 April 2023
In:	The International journal of chronic obstructive pulmonary disease Year: 2023, Volume: 18, Pages: 643-659
ISSN:	1178-2005
DOI:	10.2147/COPD.S405498
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.2147/COPD.S405498 Verlag, lizenzpflichtig, Volltext: https://www.dovepress.com/comparative-effectiveness-of-umeclidiniumvilanterol-versus-inhaled-cor-peer-reviewed-fulltext-article-COPD
Author Notes:	Alexandrosz Czira, Gema Requena, Victoria Banks, Robert Wood, Theo Tritton, Catherine M. Castillo, Jie Yeap, Rosie Wild, Chris Compton, Kieran J. Rothnie, Felix Herth, Jennifer K. Quint, Afisi S. Ismaila

Description
Summary:	Comparing adherence to once-daily UMEC/VI, a long-acting muscarinic antagonist/long-acting β2-agonist and twice-daily inhaled corticosteroids in COPD
Item Description:	Im Text ist "2" tiefgestellt Gesehen am 17.11.2023
Physical Description:	Online Resource
ISSN:	1178-2005
DOI:	10.2147/COPD.S405498